Navigation Links
Yu receives research funding from the Wallace H. Coulter Foundation
Date:9/18/2007

HOBOKEN, N.J. -- Stevens Institute of Technology Professor Xiaojun Yu, Ph.D., has received an Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation. This award will support his research titled, Novel structured nanofibrous scaffolds for bone healing.

Yu, Assistant Professor in the Department of Chemical, Biomedical and Materials Engineering at Stevens Schaefer School of Engineering and Science, is focusing his research on the treatment of bone injury in hard tissue trauma. This type of trauma creates large gaps in the bone tissue, requiring a bone grafting procedure as treatment. It has been found that polymeric nanofiber matrices have the potential to be used as bone grafts; however, due to manufacturing techniques there is restriction in the fabrication of nanofibers into complex three-dimensional (3D) structures necessary for effective treatment, resulting in mechanical properties that are not sufficient for direct bone tissue engineering applications.

Yu has proposed a way to overcome this challenge by incorporating nanofibers onto biodegradable polymeric 3D scaffolds which have optimal porosity due to its open geometrics and large surface area permitting the necessary nutrient transport and cell penetration into the scaffold for successful repair of large bone defects. As a result, biodegradable polymeric 3D scaffolds can provide sufficient mechanical properties and eventually be applied universally in the treatment of bone injuries.

Yu, principal investigator for the research, is working in conjunction with Cato T. Laurencin, M.D., Ph.D., University Professor of Orthopaedic Surgery at the University of Virginia, and Michelle Kofron, Ph.D., recent doctoral graduate of Orthopaedic Surgery at the University of Virginia.


'/>"/>

Contact: Maria Molina
mmolina@stevens.edu
201-216-5116
Stevens Institute of Technology
Source:Eurekalert

Page: 1

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
6. Researchers discover way to make cells in the eye sensitive to light
7. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
8. Columbia research lifts major hurdle to gene therapy for cancer
9. Researchers find how protein allows insects to detect and respond to pheromones
10. Researchers Uncover Key Step In Manufacture of Memory Protein
11. Research advances quest for HIV-1 vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: